No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 28,445 | 31,039 | 37,382 | 32,779 | 29,488 | 28,945 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 353 | 157 | 609 | -1,606 | -2,903 | -1,046 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
ADAMA Ltd., along with its affiliated companies, operates primarily in the agricultural sector as a crop protection enterprise. Its operations are divided into two key segments: Crop Protection (Agro), and Intermediates and Ingredients. Within its Crop Protection division, ADAMA develops, manufactures, and markets essential products such as herbicides, insecticides, and fungicides. These are designed to assist farmers in safeguarding their crops against threats like weeds, insects, and plant diseases. The Intermediates and Ingredients segment supplies a diverse range of chemical compounds, including various food additives, Lycopan (an anti-oxidation agent), synthetic aromatic substances, dietary supplements, food colorants, and components for enhancing texture and flavor. It also provides ingredients for food fortification and other specialized chemicals. Beyond these core offerings, the company manufactures fragrance products utilized across the perfume, cosmetics, body care, and detergent industries. It also delivers industrial goods, formulations, flame retardants, non-agricultural items, and comprehensive consumer and professional solutions. ADAMA maintains a significant global presence, conducting business across Europe, North America, Latin America, the Asia Pacific region, India, the Middle East, and Africa. The company, established in 1945 and headquartered in Jingzhou, Hubei, was formerly known as Hubei Sanonda Co., Ltd. It adopted its current name, ADAMA Ltd., in December 2018 and operates as a subsidiary of Syngenta Group Co., Ltd.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
ADAMA Ltd., along with its affiliated companies, operates primarily in the agricultural sector as a crop protection enterprise. Its operations are divided into two key segments: Crop Protection (Agro), and Intermediates and Ingredients. Within its Crop Protection division, ADAMA develops, manufactures, and markets essential products such as herbicides, insecticides, and fungicides. These are designed to assist farmers in safeguarding their crops against threats like weeds, insects, and plant diseases. The Intermediates and Ingredients segment supplies a diverse range of chemical compounds, including various food additives, Lycopan (an anti-oxidation agent), synthetic aromatic substances, dietary supplements, food colorants, and components for enhancing texture and flavor. It also provides ingredients for food fortification and other specialized chemicals. Beyond these core offerings, the company manufactures fragrance products utilized across the perfume, cosmetics, body care, and detergent industries. It also delivers industrial goods, formulations, flame retardants, non-agricultural items, and comprehensive consumer and professional solutions. ADAMA maintains a significant global presence, conducting business across Europe, North America, Latin America, the Asia Pacific region, India, the Middle East, and Africa. The company, established in 1945 and headquartered in Jingzhou, Hubei, was formerly known as Hubei Sanonda Co., Ltd. It adopted its current name, ADAMA Ltd., in December 2018 and operates as a subsidiary of Syngenta Group Co., Ltd.

